Publicaciones en colaboración con investigadores/as de University Medical Center Freiburg (36)

2023

  1. Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi

    Molecular Therapy Nucleic Acids, Vol. 34

2022

  1. High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis

    Blood, Vol. 139, Núm. 10, pp. 1557-1563

  2. Identifying the Common Genetic Basis of Antidepressant Response

    Biological Psychiatry Global Open Science, Vol. 2, Núm. 2, pp. 115-126

2021

  1. Association of polygenic score for major depression with response to lithium in patients with bipolar disorder

    Molecular Psychiatry, Vol. 26, Núm. 6, pp. 2457-2470

  2. Correction: Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank (Molecular Psychiatry, (2020), 25, 7, (1430-1446), 10.1038/s41380-019-0546-6)

    Molecular Psychiatry

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. Red blood cell fatty acids and risk of colorectal cancer in the European Prospective investigation into cancer and nutrition (EPIC)

    Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 5, pp. 874-885

2020

  1. A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank

    Nature Communications, Vol. 11, Núm. 1

  2. Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank

    Molecular Psychiatry, Vol. 25, Núm. 7, pp. 1430-1446

  3. Healthy lifestyle and the risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition study

    International Journal of Cancer, Vol. 147, Núm. 6, pp. 1649-1656

  4. Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

    International Journal of Cancer, Vol. 147, Núm. 5, pp. 1315-1324

2019

  1. Assessment of bidirectional relationships between physical activity and depression among adults a 2-sample Mendelian randomization study

    JAMA Psychiatry, Vol. 76, Núm. 4, pp. 399-408

  2. Identification of common genetic risk variants for autism spectrum disorder

    Nature Genetics, Vol. 51, Núm. 3, pp. 431-444

  3. Integrated analysis of environmental and genetic influences on cord blood DNA methylation in new-borns

    Nature Communications, Vol. 10, Núm. 1

  4. Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women from the European Prospective Investigation into Cancer and Nutrition

    American Journal of Epidemiology, Vol. 188, Núm. 2, pp. 274-281

2018

  1. Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder

    Communications Biology, Vol. 1, Núm. 1

  2. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression

    Nature Genetics, Vol. 50, Núm. 5, pp. 668-681

  3. Genome-wide interaction study of a proxy for stress-sensitivity and its prediction of major depressive disorder

    PLoS ONE, Vol. 13, Núm. 12

  4. Subjective positive and negative sleep variables differentially affect cellular immune activity in a breast cancer survivor: A time-series analysis approach

    Frontiers in Neurology, Vol. 8, Núm. JAN

2017

  1. Genetic association of major depression with a typical features and obesity-related immunometabolic dysregulations

    JAMA Psychiatry, Vol. 74, Núm. 12, pp. 1214-1225